VanEck Associates
CHE icon

VanEck Associates’s Chemed CHE Stock Holding History

VanEck Associates’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.26M Sell
13,437
-1,364
-9% -$573K ﹤0.01% 777
2026
Q1 		$5.59M Buy
14,801
+520
+4% +$223K ﹤0.01% 778
2025
Q4 		$6.11M Sell
14,281
-335
-2% -$146K 0.01% 724
2025
Q3 		$6.54M Sell
14,616
-377
-3% -$171K 0.01% 663
2025
Q2 		$7.3M Sell
14,993
-1,501
-9% -$855K 0.01% 583
2025
Q1 		$10.1M Buy
16,494
+1,353
+9% +$769K 0.01% 476
2024
Q4 		$8.02M Buy
15,141
+3,531
+30% +$1.99M 0.01% 532
2024
Q3 		$6.89M Buy
11,610
+3,043
+36% +$1.73M 0.01% 545
2024
Q2 		$4.65M Buy
8,567
+1,416
+20% +$811K 0.01% 605
2024
Q1 		$4.59M Buy
7,151
+2,788
+64% +$1.69M 0.01% 612
2023
Q4 		$2.55M Buy
4,363
+811
+23% +$454K ﹤0.01% 739
2023
Q3 		$1.85M Sell
3,552
-658
-16% -$342K ﹤0.01% 763
2023
Q2 		$2.28M Buy
4,210
+72
+2% +$39.4K 0.01% 695
2023
Q1 		$2.23M Buy
4,138
+1,529
+59% +$780K 0.01% 687
2022
Q4 		$1.33M Sell
2,609
-5
-0.2% -$2.43K ﹤0.01% 747
2022
Q3 		$1.14M Sell
2,614
-161
-6% -$77.4K ﹤0.01% 752
2022
Q2 		$1.3M Sell
2,775
-230
-8% -$112K ﹤0.01% 745
2022
Q1 		$1.52M Buy
3,005
+2,609
+659% +$1.25M ﹤0.01% 760
2021
Q4 		$209K Buy
396
+16
+4% +$7.68K ﹤0.01% 1103
2021
Q3 		$177K Sell
380
-1,380
-78% -$651K ﹤0.01% 1046
2021
Q2 		$835K Buy
1,760
+198
+13% +$95.1K ﹤0.01% 827
2021
Q1 		$718K Buy
1,562
+516
+49% +$253K ﹤0.01% 792
2020
Q4 		$557K Buy
1,046
+698
+201% +$343K ﹤0.01% 763
2020
Q3 		$167K Buy
+348
New +$171K ﹤0.01% 839

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

VanEck Associates's CHE Position: Q2 2026 in Review

VanEck Associates reduced its Chemed (CHE) stake by 9.2% in Q2 2026, selling an estimated $573K and leaving 13,437 shares worth $6.26M. The position accounts for ﹤0.01% of the portfolio, ranked #777.

VanEck Associates first reported a position in CHE in Q3 2020 and has held it in 24 quarters since. The position peaked at $10.1M in Q1 2025. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • VanEck Associates held 13,437 shares of Chemed worth $6.26M as of Q2 2026.
  • VanEck Associates sold 1,364 Chemed shares in Q2 2026, an estimated $573K.
  • Chemed made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #777 holding.
  • VanEck Associates first reported a position in Chemed in Q3 2020 and has held it in 24 quarters since.
  • VanEck Associates's Chemed position peaked at $10.1M in Q1 2025.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.